- Home
- SEMR vs BCRX Comparison
SEMR vs BCRX Comparison
Compare SEMR & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SEMR
- BCRX
- Stock Information
- Founded
- SEMR 2008
- BCRX 1986
- Country
- SEMR United States
- BCRX United States
- Employees
- SEMR N/A
- BCRX N/A
- Industry
- SEMR EDP Services
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SEMR Technology
- BCRX Health Care
- Exchange
- SEMR Nasdaq
- BCRX Nasdaq
- Market Cap
- SEMR 1.9B
- BCRX 1.7B
- IPO Year
- SEMR 2021
- BCRX 1994
- Fundamental
- Price
- SEMR $14.76
- BCRX $7.49
- Analyst Decision
- SEMR Buy
- BCRX Strong Buy
- Analyst Count
- SEMR 7
- BCRX 5
- Target Price
- SEMR $16.14
- BCRX $15.60
- AVG Volume (30 Days)
- SEMR 399.4K
- BCRX 2.4M
- Earning Date
- SEMR 11-07-2024
- BCRX 11-04-2024
- Dividend Yield
- SEMR N/A
- BCRX N/A
- EPS Growth
- SEMR N/A
- BCRX N/A
- EPS
- SEMR 0.08
- BCRX N/A
- Revenue
- SEMR $357,567,000.00
- BCRX $412,579,000.00
- Revenue This Year
- SEMR $24.21
- BCRX $37.24
- Revenue Next Year
- SEMR $19.41
- BCRX $19.30
- P/E Ratio
- SEMR $192.32
- BCRX N/A
- Revenue Growth
- SEMR 22.01
- BCRX 29.92
- 52 Week Low
- SEMR $9.64
- BCRX $4.03
- 52 Week High
- SEMR $16.42
- BCRX $8.88
- Technical
- Relative Strength Index (RSI)
- SEMR 62.59
- BCRX 48.27
- Support Level
- SEMR $13.02
- BCRX $6.92
- Resistance Level
- SEMR $14.47
- BCRX $8.25
- Average True Range (ATR)
- SEMR 0.61
- BCRX 0.46
- MACD
- SEMR 0.13
- BCRX -0.05
- Stochastic Oscillator
- SEMR 88.85
- BCRX 45.71
About SEMR SEMrush Holdings Inc.
SEMrush Holdings Inc is engaged in the provision of an online visibility management software-as-a-service platform. Its platform enables subscribers to improve their online visibility and drive traffic, including on their websites and social media pages, and distribute highly relevant content to their customers on a targeted basis across various channels to drive high-quality traffic and measure the effectiveness of their digital marketing campaigns. Geographically, it generates revenues from the US, the UK, and other regions.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.